Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • RDW vs GSK✓SelectedUSD · GSKRDW vs GSK performance historyLatest closeAs of-13.21%11/20
Stock and ETF performance explorer

RDW vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-61.7%
GSK return
-4.9%
Excess return
-56.8%
Maximum drawdown
-78.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-13.2%-0.1%-13.1%-13.2%
7D-26.9%-5.3%-21.6%-26.5%
30D-34.0%-3.7%-30.3%-33.4%
3M-52.0%-7.3%-44.7%-50.6%
6M-61.7%-4.2%-57.5%-62.2%
All-61.7%-4.9%-56.8%-62.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling